These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 32404958)
1. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease. Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308 [TBL] [Abstract][Full Text] [Related]
3. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060 [TBL] [Abstract][Full Text] [Related]
4. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases. Xing D; Adams E; Huang J; Ronnett BM Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305 [TBL] [Abstract][Full Text] [Related]
5. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372 [TBL] [Abstract][Full Text] [Related]
6. Precise DNA genotyping diagnosis of hydatidiform mole. Lipata F; Parkash V; Talmor M; Bell S; Chen S; Maric V; Hui P Obstet Gynecol; 2010 Apr; 115(4):784-794. PubMed ID: 20308840 [TBL] [Abstract][Full Text] [Related]
7. [Clinical application of STR genotyping diagnosis for hydatidiform mole and nonmolar gestation]. Zheng XZ; Qin XY; Wang P; Xu F; Ma JH; Wang XL; Chen SW; Feng WQ; Zhu L; Yin CH; Wu BQ Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):609-615. PubMed ID: 30107666 [No Abstract] [Full Text] [Related]
8. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping. Bynum J; Murphy KM; DeScipio C; Beierl K; Adams E; Anderson D; Vang R; Ronnett BM Int J Gynecol Pathol; 2016 Mar; 35(2):134-41. PubMed ID: 26535984 [TBL] [Abstract][Full Text] [Related]
9. Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution. Xing D; Adams E; Zou YS; Morsberger L; Scanga LR; Gao FF; Barker N; Vang R; Ronnett BM Am J Surg Pathol; 2022 Sep; 46(9):1180-1195. PubMed ID: 35796652 [TBL] [Abstract][Full Text] [Related]
10. Malignant potential of homozygous and heterozygous complete moles. Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983 [TBL] [Abstract][Full Text] [Related]
11. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656 [TBL] [Abstract][Full Text] [Related]
12. The propensity to malignancy of dispermic heterozygous moles. Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K Placenta; 1987; 8(3):319-26. PubMed ID: 2821529 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Combined p57KIP2 Immunohistochemistry and Fluorescent in situ Hybridization Analysis for Hydatidiform Moles Compared with Genotyping Diagnosis. Usui H; Hoshimoto K; Sato A; Kano M; Fukusato T; Nakatani Y; Shozu M Int J Gynecol Pathol; 2024 Sep; 43(5):474-486. PubMed ID: 38291567 [TBL] [Abstract][Full Text] [Related]
14. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance. Xing D; Miller K; Beierl K; Ronnett BM Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808 [TBL] [Abstract][Full Text] [Related]
15. When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease. McMahon L; Maher GJ; Joyce C; Niemann I; Fisher R; Sunde L Gynecol Obstet Invest; 2024; 89(3):198-213. PubMed ID: 37245506 [TBL] [Abstract][Full Text] [Related]
16. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791 [TBL] [Abstract][Full Text] [Related]
17. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Niemann I; Hansen ES; Sunde L Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616 [TBL] [Abstract][Full Text] [Related]
18. Genetics of gestational trophoblastic disease. Fisher RA; Maher GJ Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819 [TBL] [Abstract][Full Text] [Related]
19. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China. Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419 [TBL] [Abstract][Full Text] [Related]